EMPIRICAL USE OF ANTIBIOTICS POCKET GUIDELINES FOR PRESCRIBING IN ADULTS 2014/2015

Size: px
Start display at page:

Download "EMPIRICAL USE OF ANTIBIOTICS POCKET GUIDELINES FOR PRESCRIBING IN ADULTS 2014/2015"

Transcription

1 EMPIRICAL USE OF ANTIBIOTICS POCKET GUIDELINES FOR PRESCRIBING IN ADULTS 2014/2015 Full guidelines are available on the intranet (the HUB) All doses are based on NORMAL RENAL FUNCTION For dosing in renal impairment contact you ward pharmacist This is an aid for initial antibiotic prescribing. All antibiotic prescriptions should be reviewed daily and consider further discussion with Microbiology, particularly if the initial presentation is complex (e.g. immunocompromised patients outside of the neutropenic sepsis protocol, returning traveler etc.) or if there is poor clinical response. Indication and duration / review date must be written on the drug chart at time of prescribing. For further advice contact Consultant Microbiologist: Dr Cherian (ext3342) Dr Edwards (ext 1249) Antimicrobial Pharmacist: Sarah Zeraschi (bleep 6347) Pharmacy Medicines Information: (ext 3788) Out of hours, contact switchboard for on-call Microbiology and/or Pharmacist Produced by: Antimicrobial Stewardship Committee Approved: June 2014 Review: June 2015 (adapted from UCLH antimicrobial pocket guide) EMPIRICAL TREATMENT PRINCIPALS OF GOOD ANTIBIOTIC PRESCRIBING START SMART: Take cultures before antibiotic administration Check allergy history and document nature of severity Prescribe in line with BTUH policies / guidelines Give first dose of antibiotic within 1 hour for severe / life-threatening infections Document indication for antibiotic in medical notes and on drug chart Record duration of therapy (stop / review date) on drug chart Consult microbiology when appropriate THEN FOCUS: At 48 hours review diagnosis and need for antibiotics. STOP antibiotics if no evidence of infection SWITCH from IV to oral therapy CHANGE antibiotics: de-escalate / substitute / add agents as per culture results CONTINUE and review again after a further 24 hours Document decisions in medical notes. For hospital acquired infections check culture and sensitivity results before starting antibiotics. PRESCRIBING IN PENICILLIN ALLERGY Drugs in RED are contra-indicated in penicillin allergy Drugs in ORANGE should be prescribed with caution Drugs in GREEN are considered safe - See Penicillin allergy (PenA) table for more information

2 Start antibiotics within 1 hour for severe / life-threatening infections Blood Cultures must be taken Mandatory Sepsis criteria See Sepsis Care pathway Suspicion of infection AND 2 or more of the following: Temperature <36oC or >38oC Respiratory rate >20 BPM Heart rate >90 BPM WCC <4 or >12 x 109/L Septicaemia (unknown source) Severe systemic infection before results available Refer to surviving sepsis guideline 1st line: Piperacillin/ tazobactam 4.5g IV TDS + Gentamicin 5mg/kg IV stat Non-severe Penicillin allergy (e.g. delayed rash): Meropenem 1g IV TDS + Gentamicin 5mg/kg IV stat Severe Penicillin allergy (i.e. anaphylaxis): Ciprofloxacin 400mg IV BD + Teicoplanin 400mg IV BD for 3 doses then 400mg IV OD + Gentamicin 5mg/kg IV stat Neutropenic sepsis (Full guidance available on HUB) Febrile neutropenia is defined as Temperature >38oC for more than 1 hour or a single reading >38.5oC and Neutrophil count of <0.5x109/litre or count of <1x109/litre with predicted decrease to <0.5x109/litre 1st line: Meropenem 1g IV TDS SEPSIS Penicillin allergy: Ciprofloxacin 400mg IV BD + Teicoplanin 400mg IV BD for 3 doses and then 400mg IV OD + Gentamicin 5mg/kg IV if patient remains hypotensive after IV fluid resuscitation For all other groups of patients, refer to full guideline on the HUB Community Acquired Pneumonia (CAP) See CAP care pathway Severity of CAP criteria (CURB-65) - 1 point for each C onfusion (new onset) U rea > 7mmol/L R espiratory rate 30/minute B lood pressure (SBP < 90mmHg; DBP 60mmHg) 65 age 65 years Mild CAP (CURB-65 score 0-1) 1st line: Amoxicillin 500mg PO TDS Penicillin allergy: Clarithromycin 500mg PO BD Total duration: 5-7 days Moderate CAP (CURB-65 score 2) 1st line: Amoxicillin 500mg - 1g PO TDS + Clarithromycin 500mg PO BD Penicillin allergy: Clarithromycin 500mg PO BD RESPIRATORY

3 Total duration: 7-10 days Severe CAP (CURB -65 score 3) 1st line: Co-amoxiclav 1.2g IV TDS + Clarithromycin 500mg PO/IV BD Mild Penicillin allergy: Ertapenem 1g IV OD + Clarithromycin 500mg PO/IV BD Penicillin allergy: Teicoplanin 400mg IV BD for 3 doses then 400mg OD + Clarithromycin 500mg IV/PO BD Switch to oral when appropriate: Discuss with Microbiology Total duration: days Hospital acquired pneumonia (HAP) 1st line: Piperacillin/ tazobactam 4.5g IV TDS Mild Penicillin allergy: Meropenem 1g IV TDS Test for legionella antigen (urine) in moderate and severe CAP Penicillin allergy: Teicoplanin 400mg IV BD for 3 doses, then 400mg IV OD Switch to oral when appropriate: Total duration: 5-7 days Legionella Pneumonia Consider in HAP; - Inpatient - Living in an institution - Recent hospital admission - Travel History 1st line: Clarithromycin 500mg IV BD NB check urinary antigen (rapid diagnostic test). Positive contact microbiology Negative stop clarithromycin Community Acquired Aspiration pneumonia Review diagnosis after 5 days. Many do NOT require further antibiotics. 1st line: Amoxicillin 500mg PO/IV TDS + Metronidazole 400mg PO TDS or 500mg IV TDS Penicillin allergy: Clarithromycin 500mg IV/PO BD + Metronidazole 400mg PO TDS or 500mg IV TDS Hospital Acquired Aspiration pneumonia Review diagnosis after 5 days. Many do NOT require further antibiotics. 1st line: Piperacillin/tazobactam 4.5g IV TDS Mild Penicillin allergy: Meropenem 1g IV TDS Penicillin allergy: Teicoplanin 400mg IV BD for 3 doses, then 400mg IV OD + Metronidazole 400mg PO TDS or 500mg IV TDS Infective exacerbation of COPD 1st line: Doxycycline 100mg PO BD for 7 days If intolerant to tetracyclines, amoxicillin can be used. URINARY TRACT Uncomplicated, Lower UTI See UTI care pathway 1st Line: Nitrofurantoin 100mg PO QDS for 3 days for women, 7 days for men (ineffective if egfr <60ml/min)

4 If egfr <60ml/min then use Trimethoprim 200mg BD for 3 days (men 7 days) 2nd Line: Gentamicin 5mg/kg IV OD Complicated UTI & Pyelonephritis 1st Line: Gentamicin 5mg/kg IV OD Do NOT delay treatment Start treatment as soon as blood cultures have been taken 1st Line: Ceftriaxone 2g IV BD (Give IM if no venous access) for 7-14 days Severe Penicillin allergy: Chloramphenicol 1g IV QDS for 7-14 days If Listeria suspected (e.g. patient pregnant or immunosuppressed or age>55 years): Add Amoxicillin 2g IV 4 hourly If Listeria suspected and penicillin allergic speak to microbiology If gram positive cocci seen/cultured or if pneumococcal aetiology is likely (e.g. age>50yrs; sinus infection /otitis media / mastoiditis; csf leak; EtOH; immunocompromised): Add Dexamethasone 0.15mg/kg IV QDS for 4 days. Must start either before, or with the first dose of antibiotic. If GCS <15, recent seizures or suspected viral encephalitis: Add Aciclovir 10mg/kg IV TDS for days Review treatment in light of CSF cultures and PCR results Cellulitis 1st Line: Benzylpenicillin 1.2g IV QDS + Flucloxacillin 1g IV QDS Switch to oral when appropriate Amoxicillin 500mg-1g PO TDS + Flucloxacillin 500mg-1g PO QDS Penicillin Allergy: Clindamycin 600mg IV QDS - Discontinue if diarrhoea develops - Discuss with microbiology If patient >65 years Switch to oral when appropriate MENINGITIS (Contact Microbiology) SKIN & WOUND MRSA: Teicoplanin 400mg IV BD for 3 doses then 400mg OD + Sodium fusidate 500mg PO TDS BONE & JOINT (Contact Microbiology) Discuss with Microbiology if MRSA suspected and in all cases of suspected prosthetic joint infection Osteomyelitis 1st Line: Flucloxacillin 1-2g IV QDS + Sodium Fusidate 500mg PO TDS Pen allergy: Teicoplanin 400mg IV BD for 3 doses then 400mg IV OD + Sodium Fusidate 500mg PO TDS Add Gentamicin 5mg/kg IV OD if Systemically Unwell Duration if acute 42 days Duration if chronic 90 days Septic Arthritis 1st Line: Benzylpenicillin 1.2g IV QDS + Flucloxacillin 1g IV QDS 2nd Line: Teicoplanin 400mg IV BD for 3 doses the 400mg OD

5 + Clindamycin 600mg QDS IV (contact microbiology if patient >65 yrs) NB discontinue clindamycin if diarrhoea develops Biliary tract infection / Liver abscess / Peritonitis 1st Line: Co-amoxiclav 1.2g IV TDS +/- Gentamicin 5mg/kg IV stat Penicillin allergy: Metronidazole 500mg IV TDS + Ciprofloxacin 400mg IV BD Total duration: 7-14 days Post-operative Gastrointestinal Sepsis (including recent instrumentation e.g. ERCP) 1st Line: Tazocin 4.5g IV TDS +/- Gentamicin 5mg/kg IV stat Penicillin allergy: Metronidazole 500mg IV TDS + Teicoplanin 400mg IV BD for 3 doses then 400mg IV OD NB not for simple post-surgical wound infections Acute Gastroenteritis Isolate the patient Avoid laxatives and anti-motility agents Correct fluid and electrolytes Mild symptoms No antibiotic therapy required GASTROINTESTINAL Moderate to severe symptoms (i.e. dehydration, bloody stools, abdominal pain, fever) Send stool sample and await cultures. If antibiotics required discuss with Microbiology CLOSTRIDIUM DIFFICILE COLITIS Isolate the patient Stop precipitating antibiotics if possible Avoid laxatives and anti-motility agents Review use of proton pump inhibitors (PPIs) Review response to therapy daily 1st Line: Metronidazole 400mg PO TDS (if strict NBM or paralytic ileus use Metronidazole 500mg IV TDS) If poor response to 1st line after one week switch to; 2nd Line: Vancomycin 125mg PO QDS (Do not give vancomycin intravenously it is not effective) PELVIC INFLAMMATORY DISEASE 1st Line: Ceftriaxone 2g IV stat + Doxycycline 100mg PO BD + Metronidazole 400mg PO TDS Penicillin allergy: If severe allergy then discuss with Microbiology Total duration: 14 days NB Gonococcal resistance is an increasing clinical problem. Please discuss outpatient treatment with either Microbiology or GU Medicine. Please discuss all cases of tubo-ovarian abscesses with microbiology.

6 MRSA SUPPRESSION THERAPY Refer to MRSA screening policy on HUB for further information. Treatment for 5 days 1st line: Mupirocin (Bactroban ) nasal ointment TDS to both nostrils Octenisan body wash OD Octenisan shampoo hair on days 2 and 4 For alternative agents in case of adverse effects or resistance contact Infection Prevention & Control IV to ORAL SWITCH CRITERIA IV reviewed daily with a view to switch to oral therapy as soon as possible, according to the following criteria: C Clinical Improvement observed: signs & symptoms of infection improving & haemodynamically stable. O Oral route not compromised (vomiting, malabsorption disorder, NBM, Swallowing difficulties, unconscious, Severe diarrhoea) N.B if fed via NG, PEG, RIG, NJ etc. consult ward Pharmacist M Markers showing a trend towards normal Apyrexial: Temp >36 C + <38 C for at least 24 hours BP stable Plus NOT more than one of: Heart rate >90bpm Respiratory Rate >20 breaths/min WCC <4 or >12 S Specific/deep seated infection (see exclusion criteria below) Exclusion Criteria Certain infections require persistent IV therapy to ensure sufficient drug levels are attained at the site of infection to optimise response: Deep abscess: Liver abscess, Cavitating pneumonia, intracranial abscess Bone & Joint infections: Septic arthritis & Osteomyelitis Emphysema Staphylococcus aureus bacteraemia Severe soft tissue infections: necrotising fasciitis, cellulitis Cystic Fibrosis/Bronchiectasis Infected implants/prosthesis Meningitis/Encephalitis Endocarditis/mediastinitis Sepsis & Neutropenic sepsis GENTAMICIN DOSING For <75 years 1st dose: 5mg/kg (max 500mg. Round up or down to nearest 20mg) Dose is calculated using a dosing weight in obese patients Dosing Weight = Ideal Body Weight X [actual Weight ideal weight] Subsequent doses: Check pre-dose level before further doses are given Pre-dose levels must be taken hours after a dose Daily U+E s If <1mg/L give the same dose at 24 hour intervals If 1-2mg/L Reduce dose to 75% of initial dose 24 hourly (Reduce dose once only. If levels still 1mg/L discuss with microbiology) If >2mg/L No further doses until level is <1 (discuss with microbiology)

7 Dose Adjustment in Renal Impairment Estimate GFR using creatinine clearance calculator Creatinine Clearance (ml/min) = [140 age (years) x ideal body weight (kg) x F] /Serum creatinine (F = 1.04 in females and 1.23 in males) egfr (ml/min) Dose 3mg/kg (max 300mg dose rounded to nearest 20mg) <10 Dose 2mg/kg (max 200mg dose rounded to nearest 20mg) Check Levels hours after 1st dose. Re-dose only when levels <1mg/L Dose Adjustment in >75 years 1st Dose: 3mg/kg (max 300mg. Dose rounded to nearest 20mg) Check Levels hours after 1st dose. Redose only when levels <1mg/L PENICILLIN ALLERGIES Not all penicillin s sound like they contain a penicillin PENICILLINS CAN KILL IF GIVEN TO A PATIENT WITH PENICILLIN ALLERGY For any antibiotics NOT listed below please contact your ward Pharmacist or Medicines Information STOP! Contraindicated in Penicillin Allergy Amoxicillin Benzylpenicillin Co-Amoxiclav (Augmentin = Amoxicillin + Clavulanic acid) Flucloxacillin Penicillin V (Phenoxymethylpenicillin) Piperacillin / Tazobactam (Tazocin ) Temocillin Ticarcillin + clavulanic acid (Timentin) CAUTION! Use with caution in Penicillin Allergy Consult Microbiology before prescribing AVOID if history of severe allergy. CAUTION if non-severe allergy Cefalexin Ceftriaxone Meropenem Cefixime Cefuroxime Aztreonam Cefotaxime Ertapenem Ceftazidime Imipenem Approximately 10% of penicillin sensitive patients may be sensitive to a drug in this group. SAFE! Considered Safe in Penicillin Allergy Amikacin Fosfomycin Sodium Fusidate Azithromycin Gentamicin Teicoplanin Chloramphenicol Levofloxacin Tetracycline Clarithromycin Linezolid Trimethoprim Clindamycin Lymecycline Tobramycin Colistin Metronidazole Vancomycin Co-Trimoxazole Minocycline Daptomycin Nitrofurantoin Doxycycline Oxytetracycline Erythromycin Rifampicin

Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia

Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia Document Information Version: 2 Date: June 2014 Authors (incl. job title): Professor David Rees, Sue Height (consultant

More information

Antibiotic Guidelines: Ear Nose and Throat (ENT) Infections. Contents

Antibiotic Guidelines: Ear Nose and Throat (ENT) Infections. Contents Antibiotic Guidelines: Ear Nose and Throat (ENT) Infections. Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine

More information

Title: Antibiotic Guideline for Acute Pelvic Inflammatory Disease

Title: Antibiotic Guideline for Acute Pelvic Inflammatory Disease Title: Antibiotic Guideline for Acute Pelvic Inflammatory Disease Version 3 Date ratified December 2007 Review date December 2009 Ratified by NUH Antimicrobial Guidelines Committee Gynaecology Directorate

More information

POAC CLINICAL GUIDELINE

POAC CLINICAL GUIDELINE POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal

More information

ANTIBIOTICS IN SEPSIS

ANTIBIOTICS IN SEPSIS ANTIBIOTICS IN SEPSIS Jennifer Curello, PharmD, BCPS Clinical Pharmacist, Infectious Diseases Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center October 27, 2014 The power of antibiotics

More information

SECTION 6 THERAPEUTIC DRUG MONITORING

SECTION 6 THERAPEUTIC DRUG MONITORING SECTION 6 THERAPEUTIC DRUG MONITORING Kieran Hand Consultant Pharmacist Anti-infectives The objectives of this section are: To test your ability to monitor serum levels for drugs with a narrow therapeutic

More information

Urinary Tract Infections

Urinary Tract Infections Urinary Tract Infections Overview A urine culture must ALWAYS be interpreted in the context of the urinalysis and patient symptoms. If a patient has no signs of infection on urinalysis, no symptoms of

More information

Date: November 30, 2010

Date: November 30, 2010 Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Date: November 30, 2010 To: Through: From: Subject: Drug Name(s): Application

More information

Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products

Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Drug Use Review Date: April 5, 2012 To: Through: Edward Cox, M.D. Director

More information

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN CANCER PATIENTS 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN CANCER PATIENTS 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN CANCER PATIENTS 1. Aim/Purpose of this Guideline 1.1. Systemic cancer treatments and immunological therapies can suppress the ability of the bone

More information

Appropriate Treatment for Children with Upper Respiratory Infection

Appropriate Treatment for Children with Upper Respiratory Infection BCBS ACO Measure Appropriate Treatment for Children with Upper Respiratory Infection HEDIS Measure CPT II coding required: YES Click here to go to Table of Contents BCBS Measure: Page 50 of 234 Dated:

More information

PRMCE ANTI-INFECTIVES SELECTION GUIDELINE FOR ADULTS

PRMCE ANTI-INFECTIVES SELECTION GUIDELINE FOR ADULTS PRMCE ANTI-INFECTIVES SELECTION GUIDELINE FOR ADULTS SKIN AND SOFT TISSUE INFECTIONS: Mild A. Cellulitis: MRSA uncommonly causes cellulitis in the absence of a wound abscess. Add empiric anti-mrsa therapy

More information

Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis

Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis Antibiotic-Associated Diarrhea, Clostridium difficile- Associated Diarrhea and Colitis ANTIBIOTIC-ASSOCIATED DIARRHEA Disturbance of the normal colonic microflora Leading to alterations in bacterial degradation

More information

Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013

Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Amikacin AK Amoxicillin + Clavulanic acid AUG (+) ATCC 352 Coagulasenegative staphylococci Amoxicillin + Clavulanic

More information

Thank you for your Freedom of Information request concerning Antibiotic policy/guidelines.

Thank you for your Freedom of Information request concerning Antibiotic policy/guidelines. Dear Thank you for your Freedom of Information request concerning Antibiotic policy/guidelines. I would be grateful if you could provide me with an electronic copy of your trust s antibiotic guidelines/policy,

More information

Dosing information in renal impairment

Dosing information in renal impairment No. Drug name Usual dose Adjustment for Renal failure estimated CrCl (ml/min) Aminoglycoside antibiotics 1 Amikacin 2 Gentamicin 7.5 mg /kg q 12 hr > 50-90 7.5 mg/kg q 12 hr 10-50 7.5 mg/kg q 24 hr < 10

More information

PACKAGE LEAFLET. CLINDAMYCIN capsules Clidamycin. One capsule of 75 mg contains 75 mg Clindamycin (as hydrochloride).

PACKAGE LEAFLET. CLINDAMYCIN capsules Clidamycin. One capsule of 75 mg contains 75 mg Clindamycin (as hydrochloride). PACKAGE LEAFLET CLINDAMYCIN capsules Clidamycin COMPOSITION One capsule of 75 mg contains 75 mg Clindamycin (as hydrochloride). One capsule of 150 mg contains 150 mg Clindamycin (as hydrochloride). PROPERTIES

More information

INTRAVENOUS DRUG QUICKGUIDE

INTRAVENOUS DRUG QUICKGUIDE INTRAVENOUS DRUG QUICKGUIDE GENERAL NOTES IMPORTANT THIS GUIDE IS AN AIDE MEMOIRE ONLY, AND SHOULD NOT REPLACE YOUR PROFESSIONAL REQUIREMENT TO USE MANUFACTUER S LICENSED INFORMATION TO INFORM YOUR PREPARATION

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES:

More information

Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer )

Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer ) Departments of Haematology, Nephrology and Pharmacy Care Pathway for the Administration of Intravenous Iron Sucrose (Venofer ) [Care Pathway Review Date] Guidance for use This Care Pathway is intended

More information

NewYork-Presbyterian Hospital Sites: Columbia University Medical Center Guideline: Medication Use Manual Page 1 of 12

NewYork-Presbyterian Hospital Sites: Columbia University Medical Center Guideline: Medication Use Manual Page 1 of 12 Page 1 of 12 TITLE: ANTIBIOTICS IN ADULT PATIENTS EMPIRIC USE GUIDELINES, COLUMBIA UNIVERSITY MEDICAL CENTER MEDICATION GUIDELINE PURPOSE: These are the 2011 guidelines for the empiric use of antibiotics

More information

Primary Options for Acute Care: Management of Adult Cellulitis

Primary Options for Acute Care: Management of Adult Cellulitis Primary Options for Acute Care: Management of Adult Cellulitis These guidelines provide support for IV Management of Cellulitis in the community for initial oral treatment has failed. This is to be used

More information

Intra-abdominal abdominal Infections

Intra-abdominal abdominal Infections Intra-abdominal abdominal Infections Marnie Peterson, Pharm.D., BCPS Dept. of Pediatric Infectious Diseases Medical School University of Minnesota Intra-abdominal abdominal Infections Intra-abdominal abdominal

More information

Antimicrobial Audit. Philip Howard Consultant Antimicrobial Pharmacist. Medicines Management & Pharmacy Services

Antimicrobial Audit. Philip Howard Consultant Antimicrobial Pharmacist. Medicines Management & Pharmacy Services Antimicrobial Audit Philip Howard Consultant Antimicrobial Pharmacist Leeds Teaching Hospitals NHS Trust (North of England) Serves population 900k plus 2.5m for tertiary services ~ 2300 inpatient beds

More information

PPP 1. Continuation of a medication to ensure continuity of care

PPP 1. Continuation of a medication to ensure continuity of care PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The

More information

Antimicrobial Stewardship for Hospital Acquired Infection Prevention: Focus on C. difficile infection

Antimicrobial Stewardship for Hospital Acquired Infection Prevention: Focus on C. difficile infection Antimicrobial Stewardship for Hospital Acquired Infection Prevention: Focus on C. difficile infection Emi Minejima, PharmD Assistant Professor of Clinical Pharmacy USC School of Pharmacy minejima@usc.edu

More information

Adult Antimicrobial Guidelines 2011-2013. Cork University Hospital

Adult Antimicrobial Guidelines 2011-2013. Cork University Hospital Adult Antimicrobial Guidelines 2011-2013 Cork University Hospital your hands wash your hands wash your hands wash your hands wash your hands wash your hands wash your hands wash your hands wash your hands

More information

Therapeutic protocoles for adults concerning ESBL Enterobacteria infections in health care institutions

Therapeutic protocoles for adults concerning ESBL Enterobacteria infections in health care institutions Therapeutic protocoles for adults concerning ESBL Enterobacteria infections in health care institutions CYSTITIS The growing importance of resistance to quinolones, their environmental impact and reduced

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method

More information

Drug Utilization and Evaluation of Cephalosporin s At Tertiary Care Teaching Hospital, Bangalore

Drug Utilization and Evaluation of Cephalosporin s At Tertiary Care Teaching Hospital, Bangalore Research Article Drug Utilization and Evaluation of Cephalosporin s At Tertiary Care Teaching Hospital, Bangalore HS. Shekar 1*, HR. Chandrashekhar 2, M. Govindaraju 3, P. Venugopalreddy 1, Chikkalingiah

More information

THE OUT-OF-HOSPITAL CELLULITIS PATHWAY

THE OUT-OF-HOSPITAL CELLULITIS PATHWAY THE OUT-OF-HOSPITAL CELLULITIS PATHWAY Post holder responsible for Policy: Directorate/Department responsible for Policy: Contact details: Hugh Bakere Acute Medicine Hugh Bakere, Consultant EMU, x6261

More information

C-Difficile Infection Control and Prevention Strategies

C-Difficile Infection Control and Prevention Strategies C-Difficile Infection Control and Prevention Strategies Adrienne Mims, MD MPH VP, Chief Medical Officer Adrienne.Mims@AlliantQuality.org 1/18/2016 1 Disclosure This educational activity does not have commercial

More information

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection

Nursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection L14: Hospital acquired infection, nosocomial infection Definition A hospital acquired infection, also called a nosocomial infection, is an infection that first appears between 48 hours and four days after

More information

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years

More information

Lung Pathway Group Nintedanib (Vargatef) in advanced Non-Small Cell Lung Cancer (NSCLC)

Lung Pathway Group Nintedanib (Vargatef) in advanced Non-Small Cell Lung Cancer (NSCLC) Lung Pathway Group Nintedanib (Vargatef) in advanced Non-Small Cell Lung Cancer (NSCLC) Indication: In combination with docetaxel in locally advanced, metastatic or locally recurrent NSCLC of adenocarcinoma

More information

Staphylococcus aureus Bloodstream Infection Treatment Guideline

Staphylococcus aureus Bloodstream Infection Treatment Guideline Staphylococcus aureus Bloodstream Infection Treatment Guideline Purpose: To provide a framework for the evaluation and management patients with Methicillin- Susceptible (MSSA) and Methicillin-Resistant

More information

COMPOSITION: Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin base.

COMPOSITION: Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin base. APPROVED PACKAGE INSERT DALACIN C 150 mg CAPSULES SCHEDULING STATUS: S4 PROPRIETARY NAME (and dosage form): DALACIN C TM 150 mg (Capsules) COMPOSITION: Each capsule contains clindamycin hydrochloride equivalent

More information

STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative treatment

STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative treatment STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative Pregnancy Chlamydia Chancroid Epdidymitis Gonorrhea: Uncomplicated (cx, urethra, and rectum):

More information

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN

PATIENT INFORMATION LEAFLET. CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN PATIENT INFORMATION LEAFLET CEFALEXIN 250 mg AND 500 mg CAPSULES CEFALEXIN Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again.

More information

RECOMMENDATION FOR THE USE OF ANTIBIOTICS FOR THE TREATMENT OF INFECTION

RECOMMENDATION FOR THE USE OF ANTIBIOTICS FOR THE TREATMENT OF INFECTION RECOMMENDATION FOR THE USE OF ANTIBIOTICS FOR THE TREATMENT OF INFECTION Aims to provide a simple, best guess approach to the treatment of common infections, based on known sensitivity and resistance patterns

More information

ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES

ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES FOR USE WITH CLSI DOCUMENTS M2 AND M7 Beta-lactams: penicillins e penicillin a penicillin beta-lactam/beta-lactamase inhibitor combinations aminopenicillin a

More information

Sexually Transmitted Infections (STI) One Day Update

Sexually Transmitted Infections (STI) One Day Update Sexually Transmitted Infections (STI) One Day Update February 2015 Overview STI Guideline Changes National STI Services Results Reporting High Transmission Areas: Key Populations STI Guideline Changes

More information

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network Health.Alert@nh.gov August 13, 2015 1400 EDT (2:00 PM EDT) NH-HAN 20150813 Updated Centers for Disease Control (CDC)

More information

Sepsis Awareness Month

Sepsis Awareness Month Aon Kenya Insurance Brokers Ltd Aon Hewitt Healthcare Division Sepsis Awareness Month Issue 11 September 2015 In this Issue 2 Getting to understand Sepsis 3 Stages in Sepsis Advancement 4 Diagnosis & Treatment

More information

APPENDIX B: UWHC SURGICAL ANTIMICROBIAL PROPHYLAXIS GUIDELINES

APPENDIX B: UWHC SURGICAL ANTIMICROBIAL PROPHYLAXIS GUIDELINES APPENDIX B: UWHC SURGICAL ANTIMICROBIAL PROPHYLAXIS GUIDELINES Principles of prophylaxis 1) Use antimicrobials for surgical procedures where prophylactic antimicrobials have been found to be beneficial.

More information

Ceftriaxone Therapy Vs. Ciprofloxacin In Treatment Of Typhoid Fever In Adult Patients.

Ceftriaxone Therapy Vs. Ciprofloxacin In Treatment Of Typhoid Fever In Adult Patients. Dec QMJ VOL.5 No.8 Ceftriaxone Therapy Vs. Ciprofloxacin In Treatment Of Typhoid Fever In Adult Patients. Radhi F.Alshaibani* الخلاصھ لا زالت حمى التایفوید سببا مھما من اسباب الامراض وفقدان ساعات العمل

More information

Lung Pathway Group Pemetrexed and Cisplatin in Non-Small Cell Lung Cancer (NSCLC)

Lung Pathway Group Pemetrexed and Cisplatin in Non-Small Cell Lung Cancer (NSCLC) Indication: NICE TA181 First line treatment option in advanced or metastatic non-squamous NSCLC (histology confirmed as adenocarcinoma or large cell carcinoma) Performance status 0-1 Regimen details: Pemetrexed

More information

2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies

2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies 2015/2016 Schedule of Home Medical Services and Fees for Approved Agencies Legislative Authority: Health Insurance Act (Standard Hospital Benefit) Regulations 1971- Section 3(xv) This schedule lists the

More information

Policy for Screening Patients for MRSA Colonisation

Policy for Screening Patients for MRSA Colonisation Policy for Screening Patients for MRSA Colonisation To whom this document applies: All staff in Colchester Hospital University Foundation Trust screening Patients for MRSA Procedural Documents Approval

More information

Practice Guidelines. Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections

Practice Guidelines. Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections CARRIE ARMSTRONG Guideline source: Surgical Infection Society, Infectious Diseases Society of America Literature search described?

More information

DRUG USE EVALUATION REPORT. Investigating Meropenem usage at the Colonial War Memorial Hospital from October 2013 to October 2014

DRUG USE EVALUATION REPORT. Investigating Meropenem usage at the Colonial War Memorial Hospital from October 2013 to October 2014 DRUG USE EVALUATION REPORT Investigating Meropenem usage at the Colonial War Memorial Hospital from October 2013 to October 2014 MARCH 2015 Acknowledgements This report has been written through the collaborative

More information

LEFLUNOMIDE (Adults)

LEFLUNOMIDE (Adults) Shared Care Guideline DRUG: Introduction: LEFLUNOMIDE (Adults) Indication: Disease modifying drug for rheumatoid arthritis and psoriatic arthritis Licensing Information: Disease modifying drug for active

More information

Antibiotic resistance does it matter in paediatric clinical practice? Jette Bangsborg Department of Clinical Microbiology Herlev Hospital

Antibiotic resistance does it matter in paediatric clinical practice? Jette Bangsborg Department of Clinical Microbiology Herlev Hospital Antibiotic resistance does it matter in paediatric clinical practice? Jette Bangsborg Department of Clinical Microbiology Herlev Hospital Background The Department of Clinical Microbiology at Herlev Hospital

More information

GONORRHOEA. Use of lidocaine as a diluent when using ceftriaxone (see Appendix 1)

GONORRHOEA. Use of lidocaine as a diluent when using ceftriaxone (see Appendix 1) Key practice notes: 1 st line therapy GONORRHOEA Decreasing sensitivity of gonorrhoea to cephalosporins is now a real threat: CEFTRIAXONE 500mg IM stat first-line for all gonococcal infections AZITHROMYCIN

More information

All Wales Prescription Writing Standards

All Wales Prescription Writing Standards All Wales Prescription Writing Standards These standards should be read in conjunction with completing the All Wales Medication Chart e- learning package, available on the Learning@NHSWales internet site

More information

HSE Health Protection Surveillance Centre. Sample Root Cause Analysis Tool of Hospital-acquired Clostridium difficile Infection

HSE Health Protection Surveillance Centre. Sample Root Cause Analysis Tool of Hospital-acquired Clostridium difficile Infection Clostridium difficile Sub-Committee Health Protection Surveillance Centre Sample Root Cause Analysis Tool of Hospital-acquired Clostridium difficile Infection Version 3, January 2016 This document has

More information

Why Do Some Antibiotics Fail?

Why Do Some Antibiotics Fail? Why Do Some Antibiotics Fail? Patty W. Wright, M.D. April 2010 Objective To outline common reasons why antibiotic therapy is not successful and how this can be avoided. And to teach you a little bit about

More information

ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D.

ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D. ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D. ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS ACTIVITY DESCRIPTION Antibiotic use in the safest

More information

Cyclophosphamide/Rabbit Anti-Thymocyte Globulin for Allograft

Cyclophosphamide/Rabbit Anti-Thymocyte Globulin for Allograft INDICATIONS Cyclophosphamide/Rabbit Anti-Thymocyte Globulin for Allograft Aplastic Anaemia (patients under 40 years) PRE-ASSESSMENT Ensure pre-transplant work-up form is complete Ensure patient has triple

More information

CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H.

CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H. CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H. Clinical Faculty, CA Prevention Training Center Disclosure Information Sharon Adler MD, MPH I have no financial relationships

More information

National Chlamydia Screening Programme September 2012 PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF AZITHROMYCIN FOR CHLAMYDIA TRACHOMATIS

National Chlamydia Screening Programme September 2012 PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF AZITHROMYCIN FOR CHLAMYDIA TRACHOMATIS PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF AZITHROMYCIN FOR CHLAMYDIA TRACHOMATIS Below is a template that can be used to produce a local patient group direction (PGD) for the administration of

More information

Summary Public Assessment Report. Generics

Summary Public Assessment Report. Generics Summary Public Assessment Report Generics 875 mg + 125 mg, Film-coated tablets (Amoxicillin Trihydrate + Potassium Clavulanate) Date: 29-12-2014 1/7 Summary Public Assessment Report Generics Amoxicillin

More information

Summary Public Assessment Report. Generics. Amoxicilina + Ácido Clavulânico Ranbaxy,

Summary Public Assessment Report. Generics. Amoxicilina + Ácido Clavulânico Ranbaxy, Summary Public Assessment Report Generics Amoxicilina + Ácido Clavulânico Ranbaxy 875 mg + 125 mg, Film-coated tablets (Amoxicillin Trihydrate + Potassium Clavulanate) Date: 29-12-2014 1/7 Summary Public

More information

Docetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer

Docetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer Docetaxel + Carboplatin + Trastuzumab (TCH) Adjuvant Breast Cancer Background: A non-anthracycline based regimen for high-risk, HER 2 positive breast cancer in the adjuvant setting (BCIRG 006). Patient

More information

Rivaroxaban: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF

Rivaroxaban: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Leeds Rivaroxaban: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Amber Drug Level 3 (amber drug with monitoring requirements) We have started your

More information

Pre-operative M.R.S.A. Screening Information for Patients

Pre-operative M.R.S.A. Screening Information for Patients Infection Prevention and Control Pre-operative M.R.S.A. Screening Information for Patients This information is designed for patients undergoing MRSA screening before coming into hospital for a planned

More information

A Summary of the Guideline for the Diagnosis and Management of. Urinary Tract Infections in Long Term Care

A Summary of the Guideline for the Diagnosis and Management of. Urinary Tract Infections in Long Term Care A Summary of the Guideline for the Diagnosis and Management of Urinary Tract Infections in Long Term Care Exclusions Community acquired UTIs UTIs in acute care Prevention Limit use of catheters Ensure

More information

Treatment of sexually transmitted and other genital infections

Treatment of sexually transmitted and other genital infections www.bpac.org.nz keyword: sti Treatment of sexually transmitted and other genital infections Key reviewer: Dr Murray Reid, Sexual Health Physician, Auckland Sexual Health Service General points: If one

More information

Blue Team Teaching Module: Periorbital/Orbital Infections

Blue Team Teaching Module: Periorbital/Orbital Infections Blue Team Teaching Module: Periorbital/Orbital Infections Format: 1. Case 2. Topic Summary 3. Questions 4. References Case: A 3-year-old boy presents with 2 days of increasing redness, swelling, and pain

More information

Lothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS

Lothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS MANAGEMENT OF DIABETIC KETOACIDOSIS 90 MANAGEMENT OF DIABETIC KETOACIDOSIS Diagnosis elevated plasma and/or urinary ketones metabolic acidosis (raised H + /low serum bicarbonate) Remember that hyperglycaemia,

More information

Rhode Island Department of Health Division of Infectious Diseases and Epidemiology

Rhode Island Department of Health Division of Infectious Diseases and Epidemiology Rhode Island Department of Health Division of Infectious Diseases and Epidemiology STD (Sexually Transmitted Disease) PROGRAM Expedited Partner Therapy (EPT) for STDs Guidance for Medical Providers in

More information

Product Catalogue 2015 Clinical and Industrial Microbiology

Product Catalogue 2015 Clinical and Industrial Microbiology Product Catalogue 201 Antibiotic discs in cartridge µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs

More information

BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT )

BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT ) BCCA Protocol Summary for Palliative Treatment of Advanced Pancreatic Neuroendocrine Tumours using SUNItinib (SUTENT ) Protocol Code Tumour Group Contact Physician UGIPNSUNI Gastrointestinal Dr. Hagen

More information

Frequently Asked Questions

Frequently Asked Questions Frequently Asked Questions Testing for Gonorrhea Q1: What test should be completed for accurately diagnosing gonorrhea? A1: Testing is done with either a culture or a NAAT (nucleic acid amplification test).

More information

Non-Inpatient Parenteral Antibiotic Therapy : clinical and cost effective option

Non-Inpatient Parenteral Antibiotic Therapy : clinical and cost effective option Non-Inpatient Parenteral Antibiotic Therapy : clinical and cost effective option Dilip Nathwani Ninewells Hospital & Medical School Dundee DD1 9SY TAYSIDE OHPAT EXPERIENCE Case Study Seen in A&E or AMU

More information

Beaumont Hospital Department of Nephrology and Renal Nursing. Guideline for administering Ferinject

Beaumont Hospital Department of Nephrology and Renal Nursing. Guideline for administering Ferinject Beaumont Hospital Department of Nephrology and Renal Nursing Guideline Name: Guideline for administering Ferinject Guideline Number: 18 Guideline Version: a Developed By: Louise Kelly CNM 1 Renal Day Care

More information

Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7

Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7 Volume 12 December 2011 Table of Contents Summary of Test Changes... 3 Test Changes... 6 Human Anti-Mouse AB (HAMA), ELISA... 6 Hepatitis E Antibody (IgG, IgM)... 6 Hepatitis E Antibody (IgG)... 6 Hepatitis

More information

LDU Maths, Stats and Numeracy Support. Metric Conversions

LDU Maths, Stats and Numeracy Support. Metric Conversions Metric Conversions Here are some metric weights arranged in size order, starting with the biggest:- Kg (kilogram) g (gram) mg (milligram) mcg (microgram) Each one is a thousand (1000) times smaller than

More information

Streptococcal Infections

Streptococcal Infections Streptococcal Infections Introduction Streptococcal, or strep, infections cause a variety of health problems. These infections can cause a mild skin infection or sore throat. But they can also cause severe,

More information

Other Causes of Fever

Other Causes of Fever T e c h n i c a l S e m i n a r s Other Causes of Fever Febrile Illness Causes Fever After Seven Days Referral Relapsing Fever - Borreliosis Overview JHR Adaptation Sore Throat Overview Prevention Management

More information

RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND

RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND Monitor patient on the ward to detect trends in vital signs and to manage accordingly To recognise deteriorating trends and request relevant medical/out

More information

Vancomycin Therapeutic Drug Monitoring Vancouver Coastal Health & Providence Health Care Regional Guideline. September 27, 2011. (Version 3.

Vancomycin Therapeutic Drug Monitoring Vancouver Coastal Health & Providence Health Care Regional Guideline. September 27, 2011. (Version 3. Vancomycin Therapeutic Drug Monitoring Vancouver Coastal Health & Providence Health Care Regional Guideline Sept. 27, 2011 (Version 3.5) Developed by: Jane de Lemos, Tim Lau, Mike Legal. Endorsed by: Terri

More information

Pertussis Whooping Cough Update

Pertussis Whooping Cough Update May 3, 1 Dear Kitsap County Providers, This is an update about our current status of pertussis cases here in Kitsap County. We currently have 35 cases as outlined below. See the epidemiology curve (Figure

More information

Acute abdominal conditions Key Points

Acute abdominal conditions Key Points 7 Acute abdominal conditions Key Points 7.1 ASSESSMENT AND DIAGNOSIS Referred abdominal pain Fore gut pain (stomach, duodenum, gall bladder) is referred to the upper abdomen Mid gut pain (small intestine,

More information

When things go very wrong... a hospital on trial

When things go very wrong... a hospital on trial When things go very wrong.... a hospital on trial Patricia Snell and team Understand Objectives How things can go wrong The importance of acting on information Where human error might move to Organisation

More information

with Dr. Sarah Reid & Dr. Gina Neto

with Dr. Sarah Reid & Dr. Gina Neto Is fever dangerous? Do we need to treat it? Episode 48 Pediatric Fever with Dr. Sarah Reid & Dr. Gina Neto prepared by Claire Heslop, edited by Anton Helman, July 2014 Pediatric Fever Fever in a child

More information

CAUSES Pressure changes Respiratory infection-congestion or sinus infection

CAUSES Pressure changes Respiratory infection-congestion or sinus infection Page 1 of 6 pages NOTE Contact Surgeon before giving any medication marked with an asterisk. In an emergency or during Loss of Signal, begin appropriate treatment; then call Surgeon as soon as possible.

More information

Prevention and Recognition of Obstetric Fistula Training Package. Module 8: Pre-repair Care and Referral for Women with Obstetric Fistula

Prevention and Recognition of Obstetric Fistula Training Package. Module 8: Pre-repair Care and Referral for Women with Obstetric Fistula Prevention and Recognition of Obstetric Fistula Training Package Module 8: Pre-repair Care and Referral for Women with Obstetric Fistula Early detection and treatment If a woman has recently survived a

More information

Management of exacerbations in chronic obstructive pulmonary disease in Primary Care

Management of exacerbations in chronic obstructive pulmonary disease in Primary Care Management of exacerbations in chronic obstructive pulmonary disease in Primary Care Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with significant morbidity and mortality.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol PACKAGE LEAFLET: INFORMATION FOR THE USER PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion Paracetamol Read all of this leaflet carefully before you start using this medicine. Keep this leaflet.

More information

Dabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF

Dabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Leeds Dabigatran: Amber Drug Guidance for the prevention of stroke and systemic embolism in patients with non-valvular AF Amber Drug Level 3 (amber drug with monitoring requirements) We have started your

More information

Teriflunomide (Aubagio) 14mg once daily tablet

Teriflunomide (Aubagio) 14mg once daily tablet Teriflunomide (Aubagio) 14mg once daily tablet Exceptional healthcare, personally delivered Your Consultant Neurologist has suggested that you may benefit from treatment with Teriflunomide. The decision

More information

Hospital on Trial 15/10/2014. Objectives. The players

Hospital on Trial 15/10/2014. Objectives. The players Objectives Hospital on Trial Guys and St Thomas NHS Foundation Trust DAC Beachcroft LLP Twitter: @healthlawuk Understand How things can go wrong The importance of acting on information Where human error

More information

1.3.1.3 PACKAGE LEAFLET

1.3.1.3 PACKAGE LEAFLET Sandoz Business use only Page 1 of 8 1.3.1.3 PACKAGE LEAFLET Sandoz Business use only Page 2 of 8 Package leaflet: Information for the patient Cefuhexal 250 mg film-coated tablets Cefuhexal 500 mg film-coated

More information

Clostridium Difficile Colitis: Treatments, Guidelines, and Challenges

Clostridium Difficile Colitis: Treatments, Guidelines, and Challenges Clostridium Difficile Colitis: Treatments, Guidelines, and Challenges Brian S. Zuckerbraun, MD, FACS Henry T. Bahnson Professor of Surgery University of Pittsburgh Chief, Trauma and Acute Care Surgery

More information

Hyperosmolar Non-Ketotic Diabetic State (HONK)

Hyperosmolar Non-Ketotic Diabetic State (HONK) Hyperosmolar Non-Ketotic Diabetic State (HONK) University Hospitals of Leicester NHS Trust Guidelines for Management of Acute Medical Emergencies Management is largely the same as for diabetic ketoacidosis

More information

Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon

Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon Oregon Health Authority Center for Public Health Practice HIV/STD/TB Section Principles of

More information

California Guidelines for STD Screening and Treatment in Pregnancy

California Guidelines for STD Screening and Treatment in Pregnancy California Guidelines for STD Screening and Treatment in Pregnancy These guidelines were developed by the California Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch

More information

Haemophilus Influenzae (meningitis and invasive

Haemophilus Influenzae (meningitis and invasive Haemophilus Influenzae (meningitis and invasive disease)! Report immediately 24/7 by phone upon initial suspicion or laboratory test order PROTOCOL CHECKLIST Enter available information into Merlin upon

More information